GlassScriptPhysician profile
Leon Roby Blue
NPI 1871539890
$1,031.66
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $775 · 2020: $213 · 2021: $44.11.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $278.54 | 2019-2021 | |
| Amgen INC. | $178.34 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $98.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $80.76 | 2019 | |
| Medtronic Vascular, INC. | $50.91 | 2019-2020 | |
| Boston Scientific Corporation | $49.12 | 2019 | |
| Pfizer INC. | $46.66 | 2019-2020 | |
| Irhythm Technologies, INC. | $46.18 | 2019-2020 | |
| Philips North America LLC | $37.79 | 2020 | |
| Medtronic, INC. | $27.87 | 2021 | |
| Abiomed | $25.12 | 2019 | |
| Gilead Sciences, INC. | $24.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.46 | 2019-2020 | |
| Astellas Pharma US INC | $20.96 | 2019 | |
| Cardiovascular Systems INC. | $17.37 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $13.97 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Blue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.